8-K: Performant Financial Corporation Reports Third Quarter 2024 Results, Revenue Up 5%

Performant Financial Corporation announced a 5% increase in total revenue for the third quarter of 2024, reaching $31.5 million, while experiencing a net loss of $2.4 million.

Summary

• Performant Financial Corporation's total revenue for the third quarter of 2024 was $31.5 million, a 5% increase compared to $30.0 million in the same period last year.
• Healthcare revenues specifically increased by 6% to $30.3 million, up from $28.5 million in the prior year period.
• The company experienced a net loss of $2.4 million, or $(0.03) per diluted share, compared to a net loss of $0.6 million, or $(0.01) per diluted share, in the prior year period.
• Adjusted EBITDA was $1.9 million, slightly up from $1.8 million in the prior year period.
• Adjusted net loss was $0.8 million, or $(0.01) per diluted share, compared to an adjusted net income of $0.4 million, or $0.01 per diluted share, in the prior year period.
• The company has implemented 32 commercial programs in 2024, which are estimated to contribute between $13 and $14 million in annualized revenue at steady state.
• Performant has secured its first State Medicaid contract with New York.
• The company has reiterated its 2024 healthcare revenue guidance of $117 million to $122 million and adjusted EBITDA guidance of $4 million to $5 million.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive due to revenue growth and reiterated guidance, but tempered by the net loss and reduction in customer care services. The company is showing progress in its core business but faces challenges in profitability.

Positives

• Healthcare revenue saw a 6% increase year-over-year, indicating growth in the core business.
• The company has successfully implemented 32 commercial programs in 2024, expected to generate $13 to $14 million in annualized revenue.
• The securing of the first State Medicaid contract with New York is a significant win.
• The company has reiterated its full-year revenue and adjusted EBITDA guidance, showing confidence in their performance.

Negatives

• The company experienced a net loss of $2.4 million, a significant increase from the $0.6 million loss in the prior year period.
• Adjusted net loss was $0.8 million, compared to an adjusted net income of $0.4 million in the prior year period.
• Customer care/outsourced services revenue decreased to $1.2 million from $1.5 million in the prior year period.
• The company has decided to reduce services in the customer care line of business.

Risks

• The company's ability to generate revenue following long implementation periods associated with new customer contracts is a risk.
• Client relationships and the ability to maintain them are crucial for the company's success.
• Many customer contracts are subject to periodic renewal, are not exclusive, and do not provide for committed business volumes.
• The company faces competition in the markets in which it operates.
• The company's indebtedness and compliance with restrictive covenants in its credit agreement are potential risks.
• The company's ability to hire and retain employees with specialized skills is a risk.
• Downturns in domestic or global economic conditions and other macroeconomic factors could impact the company.
• The company's ability to generate sufficient cash flows to fund ongoing operations is a risk.
• The impact of public health pandemics such as COVID-19 on the company's business and operations is a risk.
• The impacts of a failure of the company's operating systems or technology infrastructure or those of third-party vendors and subcontractors is a risk.
• The impacts of a cybersecurity breach or related incident to the company or any of the company's third-party vendors and subcontractors is a risk.
• The adaptability of the company's technology platform to new markets and processes is a risk.
• The company's ability to invest in and utilize its data and analytics capabilities to expand its capabilities is a risk.
• The company's ability to maintain, protect and enhance its intellectual property is a risk.
• The company's ability to comply with and adapt to industry regulations and compliance demands is a risk.

Future Outlook

The company expects to deliver financial results within its originally stated range for 2024, with healthcare revenues between $117 million and $122 million and adjusted EBITDA between $4 million and $5 million. They are also focused on growth in the healthcare payment integrity market.

Management Comments

• Simeon Kohl, CEO, stated that the company's third quarter revenue and overall profitability grew as expected against a difficult year-over-year comparison.
• Simeon Kohl, CEO, mentioned that existing commercial client implementations continue to scale as expected along with the CMS RAC Region 2 contract to drive revenue growth.
• Simeon Kohl, CEO, noted that the company is capitalizing on market opportunities, including their first State Medicaid contract with New York.
• Simeon Kohl, CEO, stated that the company's contract awards across federal, commercial, and now State Medicaid clients are a testament to their growth strategy.
• Simeon Kohl, CEO, mentioned that within their commercial clients, they have implemented 32 programs during 2024, which they currently estimate to collectively contribute between $13 and $14 million in annualized revenue at steady state.
• Simeon Kohl, CEO, stated that the company's long-term focus remains on delivering value for their healthcare clients and stakeholders.
• Simeon Kohl, CEO, stated that the company has made the decision to reduce services in their customer care line of business.
• Rohit Ramchandani, CFO, stated that the combination of the company's strong year-to-date financial performance and advancements in initiatives aimed at improving profitability, gives them confidence in reiterating their healthcare revenue guidance range.
• Rohit Ramchandani, CFO, stated that they expect to deliver financial results within their originally stated range which is an achievement considering some unusual conditions in the healthcare market in 2024.

Industry Context

The company operates in the healthcare payment integrity market, which is experiencing growth. The company's focus on this market and its expansion into State Medicaid contracts aligns with industry trends towards greater scrutiny of healthcare spending and the need for efficient payment recovery solutions.

Comparison to Industry Standards

• Performant's 6% year-over-year growth in healthcare revenue is a positive sign, but it is important to compare this to the growth rates of competitors such as Cotiviti and Optum, which also operate in the healthcare payment integrity space.
• The net loss of $2.4 million is a concern, and it would be beneficial to compare this to the profitability of similar companies in the industry to assess Performant's relative performance.
• The adjusted EBITDA of $1.9 million is a modest increase, and it should be compared to the EBITDA margins of competitors to determine if Performant is operating efficiently.
• The implementation of 32 commercial programs and the estimated $13 to $14 million in annualized revenue is a positive development, but it is important to assess how this compares to the client acquisition and revenue generation of other companies in the sector.
• The securing of the first State Medicaid contract with New York is a significant win, but it is important to see if this is a trend that other companies are also experiencing.

Stakeholder Impact

• Shareholders may be concerned about the net loss, but encouraged by the revenue growth and reiterated guidance.
• Employees may be affected by the reduction in services in the customer care line of business.
• Customers will likely benefit from the company's focus on healthcare payment integrity services.
• Suppliers and creditors will be interested in the company's financial stability and growth prospects.

Next Steps

• The company will hold a conference call to discuss its third quarter 2024 results.
• The company will continue to focus on delivering value for its healthcare clients and stakeholders.
• The company will continue to implement its growth strategy in the healthcare payment integrity market.

Key Dates

Keywords

healthcare payment integrity, revenue cycle management, claims processing, eligibility verification, Medicaid, EBITDA, financial results, healthcare, payment integrity, outsourced services